Product Information
VALTYA 1 MG-50 MCG TABLET is a generic product labeled by Xiromed LLC, priced at $0.7382 per EA under NDC 70700030585. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Feb 9, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700030585
Classification
Generic
Dosage Form
KIT
Effective Date
12/17/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA204704FDA Approved
2/9/2016
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for VALTYA 1 MG-50 MCG TABLET has been published 60 times since Aug 13, 2025, and over the history we have for it it has risen 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7382 per EA |
|---|---|
| All-time high | $0.7382 (Sep 30, 2026) |
| All-time low | $0.6433 (Aug 13, 2025) |
| 52-week high | $0.7382 |
| 52-week low | $0.7272 |
| Median price | $0.7382 |
| Average price | $0.7331 |
| Largest weekly change | +8.8% (Aug 20, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ethynodiol diacetate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALTYA 1 MG-50 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALTYA 1 MG-50 MCG TABLET, manufactured by Xiromed LLC, is $0.7382 per EA (NDC 70700030585), effective Sep 30, 2026.
How has the price of VALTYA 1 MG-50 MCG TABLET changed over time?
Over the history we have for it, the NADAC for VALTYA 1 MG-50 MCG TABLET has risen 14.8%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for VALTYA 1 MG-50 MCG TABLET?
Since Aug 13, 2025, the NADAC for VALTYA 1 MG-50 MCG TABLET has ranged from a low of $0.6433 (Aug 13, 2025) to a high of $0.7382 (Sep 30, 2026), with a median of $0.7382 per EA.
Are there cheaper alternatives to VALTYA 1 MG-50 MCG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETHYNODIOL-ETH ESTRA 1 MG-35 MCG, is $0.3819 per EA — about 48% below VALTYA 1 MG-50 MCG TABLET.
Who manufactures VALTYA 1 MG-50 MCG TABLET?
VALTYA 1 MG-50 MCG TABLET (NDC 70700030585) is labeled by Xiromed LLC, and CMS classifies it as a generic product.